Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 93 entries
Sorted by: Best Match Show Resources per page
DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties.

Oncogenesis

Little AC, Sham D, Hristova M, Danyal K, Heppner DE, Bauer RA, Sipsey LM, Habibovic A, van der Vliet A.
PMID: 27694834
Oncogenesis. 2016 Oct 03;5(10):e261. doi: 10.1038/oncsis.2016.61.

Dual oxidase 1 (DUOX1) is an oxidant-generating enzyme within the airway epithelium that participates in innate airway host defense and epithelial homeostasis. Recent studies indicate that DUOX1 is suppressed in lung cancers by epigenetic silencing, although the importance of...

Cite
Little AC, Sham D, Hristova M, et al. DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties. Oncogenesis. 2016;5(10):e261doi: 10.1038/oncsis.2016.61.
Little, A. C., Sham, D., Hristova, M., Danyal, K., Heppner, D. E., Bauer, R. A., Sipsey, L. M., Habibovic, A., & van der Vliet, A. (2016). DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties. Oncogenesis, 5(10), e261. https://doi.org/10.1038/oncsis.2016.61
Little, A C, et al. "DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties." Oncogenesis vol. 5,10 (2016): e261. doi: https://doi.org/10.1038/oncsis.2016.61
Little AC, Sham D, Hristova M, Danyal K, Heppner DE, Bauer RA, Sipsey LM, Habibovic A, van der Vliet A. DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties. Oncogenesis. 2016 Oct 03;5(10):e261. doi: 10.1038/oncsis.2016.61. PMID: 27694834; PMCID: PMC5117847.
Copy Download .nbib Format: NLM
The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model.

Transplantation direct

Willems MC, Hendriks T, Lomme RM, de Man BM, van der Vliet JA.
PMID: 27500270
Transplant Direct. 2016 May 20;2(6):e80. doi: 10.1097/TXD.0000000000000591. eCollection 2016 Jun.

BACKGROUND: Immunosuppressant agents are inevitable for solid organ recipients, but may have a negative effect on wound healing that is difficult to measure because of clinical use of a polydrug regime. The evidence on mycophenolate mofetil (MMF) is scarce...

Cite
Willems MC, Hendriks T, Lomme RM, et al. The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model. Transplant Direct. 2016;2(6):e80doi: 10.1097/TXD.0000000000000591.
Willems, M. C., Hendriks, T., Lomme, R. M., de Man, B. M., & van der Vliet, J. A. (2016). The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model. Transplantation direct, 2(6), e80. https://doi.org/10.1097/TXD.0000000000000591
Willems, Martine Cm, et al. "The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model." Transplantation direct vol. 2,6 (2016): e80. doi: https://doi.org/10.1097/TXD.0000000000000591
Willems MC, Hendriks T, Lomme RM, de Man BM, van der Vliet JA. The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model. Transplant Direct. 2016 May 20;2(6):e80. doi: 10.1097/TXD.0000000000000591. eCollection 2016 Jun. PMID: 27500270; PMCID: PMC4946522.
Copy Download .nbib Format: NLM
Primary current-sensing noise thermometry in the millikelvin regime.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences

Shibahara A, Hahtela O, Engert J, van der Vliet H, Levitin LV, Casey A, Lusher CP, Saunders J, Drung D, Schurig T.
PMID: 26903094
Philos Trans A Math Phys Eng Sci. 2016 Mar 28;374(2064):20150054. doi: 10.1098/rsta.2015.0054.

The use of low-temperature platforms with base temperatures below 1 K is rapidly expanding, for fundamental science, sensitive instrumentation and new technologies of potentially significant commercial impact. Precise measurement of the thermodynamic temperature of these low-temperature platforms is crucial...

Cite
Shibahara A, Hahtela O, Engert J, et al. Primary current-sensing noise thermometry in the millikelvin regime. Philos Trans A Math Phys Eng Sci. 2016;374(2064):20150054doi: 10.1098/rsta.2015.0054.
Shibahara, A., Hahtela, O., Engert, J., van der Vliet, H., Levitin, L. V., Casey, A., Lusher, C. P., Saunders, J., Drung, D., & Schurig, T. (2016). Primary current-sensing noise thermometry in the millikelvin regime. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 374(2064), 20150054. https://doi.org/10.1098/rsta.2015.0054
Shibahara, A, et al. "Primary current-sensing noise thermometry in the millikelvin regime." Philosophical transactions. Series A, Mathematical, physical, and engineering sciences vol. 374,2064 (2016): 20150054. doi: https://doi.org/10.1098/rsta.2015.0054
Shibahara A, Hahtela O, Engert J, van der Vliet H, Levitin LV, Casey A, Lusher CP, Saunders J, Drung D, Schurig T. Primary current-sensing noise thermometry in the millikelvin regime. Philos Trans A Math Phys Eng Sci. 2016 Mar 28;374(2064):20150054. doi: 10.1098/rsta.2015.0054. PMID: 26903094.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in immunology

Veluchamy JP, Lopez-Lastra S, Spanholtz J, Bohme F, Kok N, Heideman DA, Verheul HM, Di Santo JP, de Gruijl TD, van der Vliet HJ.
PMID: 28220124
Front Immunol. 2017 Feb 06;8:87. doi: 10.3389/fimmu.2017.00087. eCollection 2017.

Therapeutic monoclonal antibodies against the epidermal growth factor receptor (EGFR) act by inhibiting EGFR downstream signaling and by eliciting a natural killer (NK) cell-mediated antitumor response. The IgG

Cite
Veluchamy JP, Lopez-Lastra S, Spanholtz J, et al. . Front Immunol. 2017;8:87doi: 10.3389/fimmu.2017.00087.
Veluchamy, J. P., Lopez-Lastra, S., Spanholtz, J., Bohme, F., Kok, N., Heideman, D. A., Verheul, H. M., Di Santo, J. P., de Gruijl, T. D., & van der Vliet, H. J. (2017). . Frontiers in immunology, 887. https://doi.org/10.3389/fimmu.2017.00087
Veluchamy, John P, et al. "." Frontiers in immunology vol. 8 (2017): 87. doi: https://doi.org/10.3389/fimmu.2017.00087
Veluchamy JP, Lopez-Lastra S, Spanholtz J, Bohme F, Kok N, Heideman DA, Verheul HM, Di Santo JP, de Gruijl TD, van der Vliet HJ. . Front Immunol. 2017 Feb 06;8:87. doi: 10.3389/fimmu.2017.00087. eCollection 2017. PMID: 28220124; PMCID: PMC5292674.
Copy Download .nbib Format: NLM
Viral DNA synthesis in isolated nuclei from adenovirus-infected KB cells.

FEBS letters

Sussenbach JS, van der Vliet PC.
PMID: 11946461
FEBS Lett. 1972 Mar;21(1):7-10. doi: 10.1016/0014-5793(72)80149-2.

No abstract available.

Cite
Sussenbach JS, van der Vliet PC. Viral DNA synthesis in isolated nuclei from adenovirus-infected KB cells. FEBS Lett. 1972;21(1):7-10doi: 10.1016/0014-5793(72)80149-2.
Sussenbach, J. S., & van der Vliet, P. C. (1972). Viral DNA synthesis in isolated nuclei from adenovirus-infected KB cells. FEBS letters, 21(1), 7-10. https://doi.org/10.1016/0014-5793(72)80149-2
Sussenbach, J S., and van der Vliet, P C.. "Viral DNA synthesis in isolated nuclei from adenovirus-infected KB cells." FEBS letters vol. 21,1 (1972): 7-10. doi: https://doi.org/10.1016/0014-5793(72)80149-2
Sussenbach JS, van der Vliet PC. Viral DNA synthesis in isolated nuclei from adenovirus-infected KB cells. FEBS Lett. 1972 Mar;21(1):7-10. doi: 10.1016/0014-5793(72)80149-2. PMID: 11946461.
Copy Download .nbib Format: NLM
Monodisperse Pt(3)Co nanoparticles as electrocatalyst: the effects of particle size and pretreatment on electrocatalytic reduction of oxygen.

Physical chemistry chemical physics : PCCP

Wang C, Wang G, van der Vliet D, Chang KC, Markovic NM, Stamenkovic VR.
PMID: 20526494
Phys Chem Chem Phys. 2010 Jul 14;12(26):6933-9. doi: 10.1039/c000822b. Epub 2010 Jun 04.

Monodisperse Pt(3)Co nanoparticles have been synthesized with size control via an organic solvothermal approach. The obtained nanoparticles were incorporated into a carbon matrix and applied as electrocatalysts for the oxygen reduction reaction to investigate the effects of particle size...

Cite
Wang C, Wang G, van der Vliet D, et al. Monodisperse Pt(3)Co nanoparticles as electrocatalyst: the effects of particle size and pretreatment on electrocatalytic reduction of oxygen. Phys Chem Chem Phys. 2010;12(26):6933-9doi: 10.1039/c000822b.
Wang, C., Wang, G., van der Vliet, D., Chang, K. C., Markovic, N. M., & Stamenkovic, V. R. (2010). Monodisperse Pt(3)Co nanoparticles as electrocatalyst: the effects of particle size and pretreatment on electrocatalytic reduction of oxygen. Physical chemistry chemical physics : PCCP, 12(26), 6933-9. https://doi.org/10.1039/c000822b
Wang, Chao, et al. "Monodisperse Pt(3)Co nanoparticles as electrocatalyst: the effects of particle size and pretreatment on electrocatalytic reduction of oxygen." Physical chemistry chemical physics : PCCP vol. 12,26 (2010): 6933-9. doi: https://doi.org/10.1039/c000822b
Wang C, Wang G, van der Vliet D, Chang KC, Markovic NM, Stamenkovic VR. Monodisperse Pt(3)Co nanoparticles as electrocatalyst: the effects of particle size and pretreatment on electrocatalytic reduction of oxygen. Phys Chem Chem Phys. 2010 Jul 14;12(26):6933-9. doi: 10.1039/c000822b. Epub 2010 Jun 04. PMID: 20526494.
Copy Download .nbib Format: NLM
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.

Oncoimmunology

de Bruin RCG, Veluchamy JP, Lougheed SM, Schneiders FL, Lopez-Lastra S, Lameris R, Stam AG, Sebestyen Z, Kuball J, Molthoff CFM, Hooijberg E, Roovers RC, Santo JPD, van Bergen En Henegouwen PMP, Verheul HMW, de Gruijl TD, van der Vliet HJ.
PMID: 29296532
Oncoimmunology. 2017 Oct 20;7(1):e1375641. doi: 10.1080/2162402X.2017.1375641. eCollection 2017.

Though Vγ9Vδ2-T cells constitute only a small fraction of the total T cell population in human peripheral blood, they play a vital role in tumor defense and are therefore of major interest to explore for cancer immunotherapy. Vγ9Vδ2-T cell-based...

Cite
de Bruin RCG, Veluchamy JP, Lougheed SM, et al. A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells. Oncoimmunology. 2017;7(1):e1375641doi: 10.1080/2162402X.2017.1375641.
de Bruin, R. C. G., Veluchamy, J. P., Lougheed, S. M., Schneiders, F. L., Lopez-Lastra, S., Lameris, R., Stam, A. G., Sebestyen, Z., Kuball, J., Molthoff, C. F. M., Hooijberg, E., Roovers, R. C., Santo, J. P. D., van Bergen En Henegouwen, P. M. P., Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, H. J. (2017). A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells. Oncoimmunology, 7(1), e1375641. https://doi.org/10.1080/2162402X.2017.1375641
de Bruin, Renée C G, et al. "A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells." Oncoimmunology vol. 7,1 (2017): e1375641. doi: https://doi.org/10.1080/2162402X.2017.1375641
de Bruin RCG, Veluchamy JP, Lougheed SM, Schneiders FL, Lopez-Lastra S, Lameris R, Stam AG, Sebestyen Z, Kuball J, Molthoff CFM, Hooijberg E, Roovers RC, Santo JPD, van Bergen En Henegouwen PMP, Verheul HMW, de Gruijl TD, van der Vliet HJ. A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells. Oncoimmunology. 2017 Oct 20;7(1):e1375641. doi: 10.1080/2162402X.2017.1375641. eCollection 2017. PMID: 29296532; PMCID: PMC5739573.
Copy Download .nbib Format: NLM
Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled Trials.

Cancers

Kim JY, Lee KH, Eisenhut M, van der Vliet HJ, Kronbichler A, Jeong GH, Shin JI, Gamerith G.
PMID: 31731818
Cancers (Basel). 2019 Nov 15;11(11). doi: 10.3390/cancers11111801.

We conducted a systematic review for evidence of the clinical efficacy of cancer immunotherapies. We searched PubMed from inception to 14 February 2018 for meta-analyses of randomized controlled trials (RCTs) of cancer immunotherapies. Re-analyses were performed to estimate the...

Cite
Kim JY, Lee KH, Eisenhut M, et al. Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. Cancers (Basel). 2019;11(11)doi: 10.3390/cancers11111801.
Kim, J. Y., Lee, K. H., Eisenhut, M., van der Vliet, H. J., Kronbichler, A., Jeong, G. H., Shin, J. I., & Gamerith, G. (2019). Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. Cancers, 11(11), . https://doi.org/10.3390/cancers11111801
Kim, Jong Yeob, et al. "Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled Trials." Cancers vol. 11,11 (2019). doi: https://doi.org/10.3390/cancers11111801
Kim JY, Lee KH, Eisenhut M, van der Vliet HJ, Kronbichler A, Jeong GH, Shin JI, Gamerith G. Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. Cancers (Basel). 2019 Nov 15;11(11). doi: 10.3390/cancers11111801. PMID: 31731818; PMCID: PMC6895783.
Copy Download .nbib Format: NLM
ICON 2020-International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy.

Sports medicine (Auckland, N.Z.)

Grävare Silbernagel K, Malliaras P, de Vos RJ, Hanlon S, Molenaar M, Alfredson H, van den Akker-Scheek I, Antflick J, van Ark M, Färnqvist K, Haleem Z, Kaux JF, Kirwan P, Kumar B, Lewis T, Mallows A, Masci L, Morrissey D, Murphy M, Newsham-West R, Norris R, O'Neill S, Peers K, Sancho I, Seymore K, Vallance P, van der Vlist A, Vicenzino B.
PMID: 34797533
Sports Med. 2021 Nov 19; doi: 10.1007/s40279-021-01588-6. Epub 2021 Nov 19.

BACKGROUND: Nine core domains for tendinopathy have been identified. For Achilles tendinopathy there is large variation in outcome measures used, and how these fit into the core domains has not been investigated.OBJECTIVE: To identify all available outcome measures outcome...

Cite
Grävare Silbernagel K, Malliaras P, de Vos RJ, et al. ICON 2020-International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy. Sports Med. 2021;doi: 10.1007/s40279-021-01588-6.
Grävare Silbernagel, K., Malliaras, P., de Vos, R. J., Hanlon, S., Molenaar, M., Alfredson, H., van den Akker-Scheek, I., Antflick, J., van Ark, M., Färnqvist, K., Haleem, Z., Kaux, J. F., Kirwan, P., Kumar, B., Lewis, T., Mallows, A., Masci, L., Morrissey, D., Murphy, M., Newsham-West, R., Norris, R., O'Neill, S., Peers, K., Sancho, I., Seymore, K., Vallance, P., van der Vlist, A., & Vicenzino, B. (2021). ICON 2020-International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy. Sports medicine (Auckland, N.Z.), . https://doi.org/10.1007/s40279-021-01588-6
Grävare Silbernagel, Karin, et al. "ICON 2020-International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy." Sports medicine (Auckland, N.Z.) vol. (2021). doi: https://doi.org/10.1007/s40279-021-01588-6
Grävare Silbernagel K, Malliaras P, de Vos RJ, Hanlon S, Molenaar M, Alfredson H, van den Akker-Scheek I, Antflick J, van Ark M, Färnqvist K, Haleem Z, Kaux JF, Kirwan P, Kumar B, Lewis T, Mallows A, Masci L, Morrissey D, Murphy M, Newsham-West R, Norris R, O'Neill S, Peers K, Sancho I, Seymore K, Vallance P, van der Vlist A, Vicenzino B. ICON 2020-International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy. Sports Med. 2021 Nov 19; doi: 10.1007/s40279-021-01588-6. Epub 2021 Nov 19. PMID: 34797533.
Copy Download .nbib Format: NLM
Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study.

Physiological reports

Toffoli EC, Sweegers MG, Bontkes HJ, Altenburg TM, Verheul HMW, van der Vliet HJ, de Gruijl TD, Buffart LM.
PMID: 34110712
Physiol Rep. 2021 Jun;9(11):e14919. doi: 10.14814/phy2.14919.

Natural killer (NK) cells are a population of innate immune cells known to play a pivotal role against tumor spread. In multiple murine models, it was shown that physical exercise had the potential to increase NK cell antitumor activity...

Cite
Toffoli EC, Sweegers MG, Bontkes HJ, et al. Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study. Physiol Rep. 2021;9(11):e14919doi: 10.14814/phy2.14919.
Toffoli, E. C., Sweegers, M. G., Bontkes, H. J., Altenburg, T. M., Verheul, H. M. W., van der Vliet, H. J., de Gruijl, T. D., & Buffart, L. M. (2021). Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study. Physiological reports, 9(11), e14919. https://doi.org/10.14814/phy2.14919
Toffoli, Elisa C, et al. "Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study." Physiological reports vol. 9,11 (2021): e14919. doi: https://doi.org/10.14814/phy2.14919
Toffoli EC, Sweegers MG, Bontkes HJ, Altenburg TM, Verheul HMW, van der Vliet HJ, de Gruijl TD, Buffart LM. Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study. Physiol Rep. 2021 Jun;9(11):e14919. doi: 10.14814/phy2.14919. PMID: 34110712; PMCID: PMC8191403.
Copy Download .nbib Format: NLM
SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: a prospective cohort study.

The Journal of infection

Mak WA, Koeleman JGM, van der Vliet M, Keuren F, Ong DSY.
PMID: 34896516
J Infect. 2021 Dec 09; doi: 10.1016/j.jinf.2021.12.003. Epub 2021 Dec 09.

OBJECTIVES: First, to describe SARS-CoV-2 T cell and antibody responses in a prospective cohort of healthcare workers that suffered from mild to moderate COVID-19 approximately one year ago. Second, to assess COVID-19 vaccine-induced immune responses in these prior-infected individuals.METHODS:...

Cite
Mak WA, Koeleman JGM, van der Vliet M, et al. SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: a prospective cohort study. J Infect. 2021;doi: 10.1016/j.jinf.2021.12.003.
Mak, W. A., Koeleman, J. G. M., van der Vliet, M., Keuren, F., & Ong, D. S. Y. (2021). SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: a prospective cohort study. The Journal of infection, . https://doi.org/10.1016/j.jinf.2021.12.003
Mak, Willem A, et al. "SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: a prospective cohort study." The Journal of infection vol. (2021). doi: https://doi.org/10.1016/j.jinf.2021.12.003
Mak WA, Koeleman JGM, van der Vliet M, Keuren F, Ong DSY. SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: a prospective cohort study. J Infect. 2021 Dec 09; doi: 10.1016/j.jinf.2021.12.003. Epub 2021 Dec 09. PMID: 34896516; PMCID: PMC8656179.
Copy Download .nbib Format: NLM
Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis.

Journal of clinical medicine

Jeong GH, Lee KH, Lee IR, Oh JH, Kim DW, Shin JW, Kronbichler A, Eisenhut M, van der Vliet HJ, Abdel-Rahman O, Stubbs B, Solmi M, Veronese N, Dragioti E, Koyanagi A, Radua J, Shin JI.
PMID: 30691103
J Clin Med. 2019 Jan 26;8(2). doi: 10.3390/jcm8020143.

Capillary leak syndrome (CLS) is a rare disease with profound vascular leakage, which can be associated with a high mortality. There have been several reports on CLS as an adverse effect of anti-cancer agents and therapy, but the incidence...

Cite
Jeong GH, Lee KH, Lee IR, et al. Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis. J Clin Med. 2019;8(2)doi: 10.3390/jcm8020143.
Jeong, G. H., Lee, K. H., Lee, I. R., Oh, J. H., Kim, D. W., Shin, J. W., Kronbichler, A., Eisenhut, M., van der Vliet, H. J., Abdel-Rahman, O., Stubbs, B., Solmi, M., Veronese, N., Dragioti, E., Koyanagi, A., Radua, J., & Shin, J. I. (2019). Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis. Journal of clinical medicine, 8(2), . https://doi.org/10.3390/jcm8020143
Jeong, Gwang Hun, et al. "Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis." Journal of clinical medicine vol. 8,2 (2019). doi: https://doi.org/10.3390/jcm8020143
Jeong GH, Lee KH, Lee IR, Oh JH, Kim DW, Shin JW, Kronbichler A, Eisenhut M, van der Vliet HJ, Abdel-Rahman O, Stubbs B, Solmi M, Veronese N, Dragioti E, Koyanagi A, Radua J, Shin JI. Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis. J Clin Med. 2019 Jan 26;8(2). doi: 10.3390/jcm8020143. PMID: 30691103; PMCID: PMC6406478.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 93 entries